account_id none on file
legal_name Alnylam Pharmaceuticals, Inc.
ticker ALNY
cik 1178670
domain alnylam.com
linkedin_company_url https://www.linkedin.com/company/alnylam-pharmaceuticals/
entry_point_account_id none on file
name Alnylam Pharmaceuticals Inc.
exchange Nasdaq
sector Health Care
hq Cambridge, MA, United States
sector index/company/sector/health-care/
calls 0 filings 48 executives 2 family 0
why_nownone on file
callsnone on file
filings
Associate Dir, Health Systems, Medical Outcomes Science Liaison (North Central) | {"ats": "greenhouse", "city": null, "state": null, "job_id": "4400662009", "remote": false, "category": "other", "func
company_statement / Sep 16, 2026 / receipt
Associate Director, Statistical Programming | {"ats": "greenhouse", "city": "Cambridge", "state": "MA", "job_id": "4400085009", "remote": false, "category": "other", "function": "retail", "location":
company_statement / Sep 15, 2026 / receipt
Associate Director, Biostatistics | {"ats": "greenhouse", "city": null, "state": null, "job_id": "4400156009", "remote": false, "category": "other", "function": "retail", "location": "United States",
company_statement / Sep 15, 2026 / receipt
Associate Scientist II, Protein Sciences | {"ats": "greenhouse", "city": null, "state": null, "job_id": "4400182009", "remote": false, "category": "other", "function": "retail", "location": "United St
company_statement / Sep 15, 2026 / receipt
Sr. Financial Analyst | {"ats": "greenhouse", "city": "Cambridge", "state": "MA", "job_id": "4404893009", "remote": false, "category": "finance_ops", "function": "other", "location": "Cambridge, MA",
company_statement / Sep 15, 2026 / receipt
Senior Nonclinical Documentation Associate | {"ats": "greenhouse", "city": "Cambridge", "state": "MA", "job_id": "4405716009", "remote": false, "category": "other", "function": "retail", "location": "
company_statement / Sep 15, 2026 / receipt
Senior Associate Scientist, Lab Automation Engineering | {"ats": "greenhouse", "city": "Cambridge", "state": "MA", "job_id": "4406429009", "remote": false, "category": "other", "function": "retail", "
company_statement / Sep 15, 2026 / receipt
2026 Reiterated Full Year Guidance
ir_statement / Sep 14, 2026 / receipt
Achieve 25%+ total revenue CAGR through YE 2030
ir_statement / Sep 14, 2026 / receipt
Invest ~30% of revenues in non-GAAP R&D, including select external innovation
ir_statement / Sep 14, 2026 / receipt
Increased 2025 Total Net Product Revenue Guidance
ir_statement / Sep 14, 2026 / receipt
Updated FY 2025 Guidance
ir_statement / Sep 14, 2026 / receipt
executives
| Michael P. Mason | Principal Financial Officer | - | receipt |
| Yvonne L. Greenstreet | Chief Executive Officer | - | receipt |
familynone on file
upcoming
changes
| 2021-10-28 | Chief Executive Officer, appointed | sec_8k |
| 2020-10-02 | President, departed | sec_8k |
| 2020-08-06 | President, departed | sec_8k |
| 2019-07-11 | Senior Vice President, departed | sec_8k |
| 2017-01-03 | Principal Financial Officer, appointed | sec_8k |
| 2016-09-19 | Executive Vice President, appointed | sec_8k |
mcp_package_hint
slug alnylam-pharmaceuticals-inc
listing_url https://steadybase.io/company/data/index.json
mcp_url https://mcp.steadybase.io/mcp
steadybase-$